McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports
05/10/2026 21:11
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports Oct 5 (Reuters) - US drug distributor McKesson MCK.N and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider Option Care Health in a transaction valued at more than $5 billion including debt, the Financial Times reported on Monday, citing people familiar with the matter.
(Reporting by Sahil Pandey in Bengaluru; Editing by Maju Samuel)
Recent news on McKesson
See all newsCencora to buy American Oncology Network in $2.4 billion deal (updated)
Cencora to buy American Oncology Network in $2.4 billion deal; shares fall
Brief: Mckesson Corp - Declares QTRLY Dividend Of $0.94 Per Share
Option Care Health jumps on $5.8 billion take-private deal
Brief: Option Care Health Co To Pay Onyx Bidco Llc Termination Fee Of $146 Million If Deal Terminated Under Certain Circumstances